Aoki FY, Boivin G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. J Clin Virol. 2009 Apr;44(4):255-261. doi: 10.1016/j.jcv.2009.01.010. PMID: 19272835
Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008 Aug;57(Suppl No. RR-7 vv):001-60. http://www.cdc.gov/. PMID: 18685555
Centers for Disease Control and Prevention. Outbreaks of avian influenza A (H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases--United States, 2004. MMWR Morb Mortal Wkly Rep. 2004 Feb;53(5):97-100. https://www.cdc.gov/. PMID: 14961001
Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Feb 22, 2006. Infect Control Hosp Epidemiol. 2006 Mar;27(3):266-270. doi: 10.1086/501539. PMID: 16532414
Colgan R, Michocki R, Greisman L, et al. Antiviral drugs in the immunocompetent host: treatment of influenza and respiratory syncytial virus infections. Am Fam Physician. 2003 Feb;67(4 Pt 2):763-766, 675. https://www.aafp.org/. PMID: 12613730
Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003 Jun;326(7401):1235. doi: 10.1136/bmj.326.7401.1235. PMID: 12791735
Fiore AE, Shay DK, Broder K, et al; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul;58(Suppl RR-8):001-52. https://www.cdc.gov/. PMID: 19644442
de Mello WA, de Paiva TM, Ishida MA, et al. The dilemma of influenza vaccine recommendations when applied to the tropics: The Brazilian case examined under alternative scenarios. Plos One. 2009;4(4):e5095. PMID: 19352506
Fiore AE, Shay DK, Broder K, et al; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008 Aug;57(Suppl RR-7):001-60. https://www.cdc.gov/. PMID: 18685555
Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics. 2007 Jan;119(1):e6-e11. doi: 10.1542/peds.2006-1694. PMID: 17200259
Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009 Apr;48(8):1003-1032. doi: 10.1086/598513. PMID: 19281331
Kempe A, Daley MF, Barrow J, et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics. 2005 Jan;115(1):146-154. PMID: 15629993
Lee VJ, Fernandez GG, Chen MI, et al. Influenza and the pandemic threat. Singapore Med J. 2006 Jun;47(6):463-470. PMID: 16752013
Lessler J, Reich NG, Brookmeyer R, et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009 May;9(5):291-300. doi: 10.1016/S1473-3099(09)70069-6. PMID: 19393959
Lye DC, Nguyen DH, Giriputro S, et al. Practical management of avian influenza in humans. Singapore Med J. 2006 Jun;47(6):471-475. PMID: 16752014
National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Aug;58(Suppl RR-10):001-8. https://www.cdc.gov/. PMID: 19713882
Montalto NJ. An office-based approach to influenza: clinical diagnosis and laboratory testing. Am Fam Physician. 2003 Jan;67(1):111-118. PMID: 12537174
Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000 Nov;160(21):3243-3247. doi: 10.1001/archinte.160.21.3243. PMID: 11088084
Roxas M, Jurenka J. Colds and influenza: A review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev. 2007 Mar;12(1):25-48. PMID: 17397266
Prisco MK. Update your understanding of influenza. Nurse Pract. 2002 Jun;27(6):32-39. http://journals.lww.com/. PMID: 12094084
Stiver G. The treatment of influenza with antiviral drugs. Can Med Assoc J. 2003 Jan;168(1):49-57. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC139319/pdf/20030107s00025p49.pdf. PMID: 12515786
Stöhr K. Preventing and treating influenza: neuraminidase inhibitors are clinically effective but have limitations. BMJ. 2003 Jun;326(7401):1223-1224. doi: 10.1136/bmj.326.7401.1223. PMID: 12791711
Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. Mar 07, 2006. PLoS Med. 2006 Apr;3(4):e89. doi: 10.1371/journal.pmed.0030089. PMID: 16509764
Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis. 2009 Jul;49(2):279-290. doi: 10.1086/600035. PMID: 19522652
Wong SS, Yuen KY. Influenza vaccination: options and issues. Hong Kong Med J. 2005 Oct;11(5):381-390. http://www.hkmj.org/. PMID: 16219958
Yeun KY, Wong SS. Human infection by avian influenza A H5N1. Hong Kong Med J. 2005 Jun;11(3):189-199. PMID: 15951584
Influenza. In: Fauci AS, Braunwald E, Kasper DL, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005
Department of Health. Antiviral prophylaxis: guidance on the use of prophylaxis with antiviral medicines during the H1N1 (swine flu) pandemic. GOV.UK. http://webarchive.nationalarchives.gov.uk/. 06 Oct 2009. Accessed 22 Nov 2010.
World Health Organization. Clinical management of human infection with new influenza A (H1N1) virus: initial guidance. WHO. http://www.who.int/. 21 May 2009. Accessed 07 Aug 2009.
World Health Organization. Clinical management of human infection with avian influenza A (H5N1) virus. WHO. http://www.who.int/. 15 Aug 2007. Accessed 09 Aug 2009.
World Health Organization Regional Office for Southeast Asia. Guidelines on laboratory diagnosis of avian influenza. WHO. http://www.searo.who.int/. 2007. Accessed 09 Aug 2009.
American Lung Association. Guidelines for the prevention and treatment of influenza and the common cold. American Lung Association. http://www.lungusa.org. 2002.
World Health Organization. Infection control recommendations for avian influenza in health-care facilities. WHO. http://www.who.int/. Apr 2008. Accessed 06 Aug 2009.
Centers for Disease Control and Prevention. Infection control measures for preventing and controlling influenza transmission in long-term care facilities. CDC. http://www.cdc.gov/. Nov 2007. Accessed 27 Aug 2009.
World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. WHO Interim Guidelines. WHO. http://www.who.int/. Jun 2007. Accessed 09 Aug 2009.
World Health Organization. Infection prevention and control in health care for confirmed or suspected cases of pandemic (H1N1) 2009 and influenza-like illnesses. WHO. http://www.who.int/. 25 Jun 2009. Accessed 07 Aug 2009.
Ministry of Health Singapore. Influenza pandemic readiness and response plan. MOH (Singapore). http://www.moh.gov.sg/. Jan 2009. Accessed 25 Aug 2009.
Centers for Disease Control and Prevention. Influenza: side effects of influenza vaccine. CDC. http://www.cdc.gov/. Accessed 27 Aug 2009.
Centers for Disease Control and Prevention. Interim guidance on case definitions to be used for investigations of novel influenza A (H1N1) cases. CDC. http://www.cdc.gov/. Jun 2009. Accessed 27 Aug 2009.
Centers for Disease Control and Prevention. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza. CDC. http://www.cdc.gov/. 21 May 2004. Accessed 12 Aug 2009.
World Health Organization. Joint WHO-OFFLU technical teleconference to discuss human-animal interference aspects of the current influenza A (H1N1) situation: meeting summary. WHO. http://www.offlu.net/. May 2009. Accessed 06 Aug 2009.
National Institute for Health and Care Excellence. NICE issues guidance on the prevention of ‘flu’ [press release]. NICE website. https://www.nice.org.uk. Sep 2003.
World Health Organization. Pandemic influenza prevention and mitigation in low resource communities. WHO. http://www.who.int/. 2008. Accessed 09 Aug 2009.
World Health Organization. Pandemic influenza vaccines: current status. WHO. http://www.who.int/. 24 Sep 2009. Accessed 06 Oct 2009.
Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. CDC. http://www.cdc.gov/. Sep 2009. Accessed 11 Sep 2009.
Centre for Health Protection. Scientific Committee on Vaccine Preventable Diseases. Recommendations on seasonal influenza vaccination for 2010/11 season. http://www.chp.gov.hk/. Aug 2010. Accessed 22 Nov 2010.
World Health Organization. WHO information for laboratory diagnosis of new influenza A (H1N1) virus in humans. WHO. http://www.who.int/. 21 May 2009. Accessed 27 Aug 2009.
World Health Organization. WHO rapid advice guidelines on pharmacological management of human infected with avian influenza A (H5N1) virus. WHO. http://www.who.int/. 2006. Accessed 09 Aug 2009.
Bridges CB, Coyne-Beasley T, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2014. MMWR Morb Mortal Wkly Rep. 2014 Feb;63(5):110-112. https://www.cdc.gov/. PMID: 24500291
Centers for Disease Control and Prevention (CDC). Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years - United States, 2014. MMWR Morb Mortal Wkly Rep. 2014 Feb;63(5):108-109. http://www.cdc.gov/. PMID: 24500290
Grohskopf L, Polsen S, Sokolow L, et al. Prevention and control of seasonal influenza with vaccines: recommendation of the Advisory Committee on Immunization Practices (ACIP) – United States, 2014-2015 Influenza season. MMWR Morb Mortal Wkly Rep. 2014 Aug;63(32):691-697. https://www.cdc.gov/. Accessed 20 Jul 2015. PMID: 25121712
Infection Control Today. CDC issues update regarding treatment of patients with influenza with antiviral medications. Infection Control Today. http://www.infectioncontroltoday.com. 2015 Jan. Accessed 20 Jul 2015.
National Guideline Clearinghouse. Guideline summary: Antiviral agents for the treatment and chemoprophylaxis of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). http://www.guideline.gov/. Accessed 20 Jul 2015.
United States Food & Drug Administration. FDA approves Rapivab to treat flu infection. US FDA. http://www.fda.gov/. Accessed 20 Jul 2015.
World Health Organization. WHO surveillance case definitions for ILI and SARI. WHO. http://www.who.int. 2015. Accessed 20 Jul 2015.
Centers for Disease Control and Prevention. ACIP votes down use of LAIV for 2016-2017 flu season. Centers for Disease Control and Prevention. https://www.cdc.gov/. Jun 2016.
Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep. 2016 Aug;65(5):1-54. doi: 10.15585/mmwr.rr6505a1. Accessed 13 Jul 2017. PMID: 27560619
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. WHO. http://www.who.int/. Feb 2016.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season. WHO. http://www.who.int/. Sep 2016.
Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 influenza season. MMWR Recomm Rep. 2017 Aug;66(2):1-20. doi: 10.15585/mmwr.rr6602a1. PMID: 28841201
Grohskopf LA, Sololow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 influenza season. MMWR Recomm Rep. 2018 Aug;67(3):1-20. doi: 10.15585/mmwr.rr6703a1. Accessed 10 Sep 2018. PMID: 30141464
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season. WHO. www.who.int. Sep 2017.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2018-2019 northern hemisphere influenza season. WHO. www.who.int. Feb 2018.
Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. CDC. https://www.cdc.gov/. Dec 2018. Accessed 11 Feb 2019.
Ministry of Health Singapore. Avian influenza. Ministry of Health Singapore. https://www.moh.gov.sg/. Nov 2018.
Stephenson I. Avian influenza A H5N1: treatment and prevention. UptoDate. https://www.uptodate.com/. Jan 2019. Accessed 11 Feb 2019.
Thorner AR. Avian influenza A H7N9: epidemiology, clinical manifestations, and diagnosis. UptoDate. https://www.uptodate.com/. Jan 2019. Accessed 11 Feb 2019.
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019 Mar;68(6):e1-e47. doi: 10.1093/cid/ciy866. Accessed 11 Feb 2019. PMID: 30566567
World Health Organization. FAQs: H5N1 influenza. WHO. http://www.who.int/. Feb 2014.
World Health Organization. Frequently asked questions on human infection caused by the avian influenza A(H7N9) virus. WHO. http://www.who.int/. Feb 2014. Accessed 11 Feb 2019.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2019-2020 northern hemisphere influenza season. WHO. https://www.who.int/. Feb 2019.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2019 southern hemisphere influenza season. WHO. https://www.who.int/. Sep 2018.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2020-2021 northern hemisphere influenza season. WHO. https://www.who.int. Feb 2020.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2020 southern hemisphere influenza season. WHO. https://www.who.int. Sep 2019.
Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. MMWR Recomm Rep. 2020 Aug;69(8):1-24. doi: 10.15585/mmwr.rr6908a1. PMID: 32820746
American Family Physician. Influenza vaccination: updated 2020-2021 recommendations from ACIP. AFP. https://www.aafp.org/. 10 Sep 2020.
Centers for Disease Control and Prevention. Interim guidance for routine and influenza immunization services during the COVID-19 pandemic. CDC. https://www.cdc.gov/. 20 Oct 2020.
Centers for Disease Control and Prevention. Testing guidance for clinicians when SARS-CoV-2 and influenza viruses are co-circulating. CDC. https://www.cdc.gov/. 16 Oct 2020.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2021 southern hemisphere influenza season. WHO. https://www.who.int. Sep 2020.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season. WHO. https://www.who.int. Feb 2021.
Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2021-22 influenza season. MMWR Recomm Rep. 2021 Aug;70(5):1-28. doi: 10.15585/mmwr.rr7005a1. PMID: 34448800
Centers for Disease Control and Prevention. Interim guidance for routine and influenza immunization services during the COVID-19 pandemic. CDC. https://www.cdc.gov/. Apr 2021.
Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2021-2022. Pediatrics. 2021 Oct;148(4):e2021053745. doi: 10.1542/peds.2021-053745. PMID: 34493538
Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 influenza season. MMWR Recomm Rep. 2021 Aug;70(5):1-28. doi: 10.15585/mmwr.rr7005a1. PMID: 34448800
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season. WHO. https://www.who.int/. Feb 2021.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season. WHO. https://www.who.int/. Sep 2021.
Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices – United States, 2021-2022 influenza season. MMWR. 70(RR-5):1-28. https://www.cdc.gov/. Accessed 26 Apr 2022
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2022-2023 northern hemisphere influenza season. WHO. 2022 Feb. https://www.who.int.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season. WHO. 2021 Sep. https://www.who.int.
World Health Organization (WHO). Guidelines for the clinical management of severe illness from influenza virus infections. WHO. 2022. https://apps.who.int/.
Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season. MMWR Recomm Rep . 2022;71(No. RR-1):1-28. http://dx.doi.org/10.15585/mmwr.rr7101a1.
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2023 southern hemisphere influenza season. WHO. https://www.who.int. Sep 2022.
World Health Organization (WHO). Recommendations announced for influenza vaccine composition for the 2023-2024 northern hemisphere influenza season. WHO. https://www.who.int/. 24 Feb 2023.
Centers for Disease Control and Prevention. Influenza prevention: information for travelers. CDC. https://www.cdc.gov. 25 Oct 2021. Accessed 21 Aug 2023.
Standing Committee on Vaccination (STIKO). Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023. Robert Koch Institut. http://www.rki.de/stiko-empfehlungen. 26 Jan 2023. Accessed 13 Sep 2023.
Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023. Government of Canada. https://www.canada.ca/. Oct 2022. Accessed 12 Sep 2023.
Australian Technical Advisory Group on Immunisation (ATAGI) Clinical Advice. Statement on the administration of seasonal influenza vaccines in 2023 . Australian Government Department of Health and Aged Care. https://www.health.gov.au/. Feb 2023. Accessed 12 Sep 2023.
Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 influenza season. MMWR Recomm Rep. 2023;72(No. RR-2):1-25. http://dx.doi.org/10.15585/mmwr.rr7202a1. Accessed 08 Sep 2023
